HIGHLIGHTS
- who: Chaos from the Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, and , In Vitro Drug Safety and Medicine, University of Toronto, Toronto, Ontario, Canada have published the paper: Risk of Infections of Biological Therapies with Accent on Inflammatory Bowel Disease, in the Journal: (JOURNAL)
- what: The aim of the present systematic review is to describe the current knowledge on the risk of infections associated with anti-TNF agents antagonists as well as integrin antagonists. The aim of this review was to present an integrative approach that bridges preclinical and clinical research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.